Compugen Story

CGEN -  USA Stock  

USD 7.82  0.02  0.26%

As many baby boomers are indifferent towards healthcare space, it makes sense to outline Compugen against current market trends. As we have suggested previously, Compugen is beginning its slide as institutional investors shift to be more bearish due to the increased sector volatility. Compugen almost neglects market trends. The returns on the market and returns on Compugen appear somewhat sensitive to each other for the last few months. Persistent technical and fundamental indicators of the company may entail signs of short-term price drift for institutional investors. Compugen is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 13th of May 2021. The stock is still going through a sell-off trend.
Published over a month ago
View all stories for Compugen | View All Stories
Should you buy Compugen (NASDAQ:CGEN) based on latest technical indicators?
Compugen's average rating is Strong Buy from 7 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Compugen market sentiment investors' perception of the future value of Compugen. Let us look at a few aspects of Compugen technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Compugen. In general, we focus on analyzing Compugen stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Compugen's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Compugen's intrinsic value. In addition to deriving basic predictive indicators for Compugen, we also check how macroeconomic factors affect Compugen price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Compugen in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Compugen. Your research has to be compared to or analyzed against Compugen's peers to derive any actionable benefits. When done correctly, Compugen's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Compugen.

How does Compugen Stands against Peers?

Analyzing Compugen competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Compugen across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Compugen Competition Details

How Compugen utilizes its cash?

To perform a cash flow analysis of Compugen, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Compugen is receiving and how much cash it distributes out in a given period. The Compugen cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Compugen Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (29.07 Million)

What is driving Compugen Investor Appetite?

This firm has a beta of 0.6646. Let's try to break down what Compugen's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Compugen will likely underperform. The beta indicator helps investors understand whether Compugen moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Compugen deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
The big decline in price over the last few months for Compugen could raise concerns from institutional investors as the firm it trading at a share price of 6.87 on 1,113,472 in volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in April. However, diversifying your holdings with Compugen or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.65. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Compugen partners.

Over 3 percent slide for Compugen. What does it mean for institutional investors?

Information Ratio just dropped to -0.2, may entail upcoming price decrease. Compugen exhibits very low volatility with skewness of -0.04 and kurtosis of 0.4. However, we advise investors to further study Compugen technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Compugen's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Compugen's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Conclusion on Compugen

Whereas some firms in the biotechnology industry are either recovering or due for a correction, Compugen may not be as strong as the others in terms of longer-term growth potentials. To conclude, as of the 12th of May 2021, our analysis shows that Compugen almost neglects market trends. The company is undervalued and projects average chance of distress for the next 2 years. Our ongoing 90 days buy-or-sell advice on the company is Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Compugen. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com